Hematology in palliative medicine.
Advanced cancer and life-limiting chronic nonmalignant diseases are associated with a number of hematological problems. Anemia and coagulation disorders, principally venous thrombosis and thrombocytopenia, are most commonly observed. Patients undergoing chemotherapy and bone marrow transplant have unique problems that include neutropenias and chemotherapy-induced drug toxicities, which will not be covered in this article.
Davis
Mellar P
MP
The Harrny R. Horvitz Center for Palliative Medicine, Cleveland Taussig Cancer Center, Cleveland, Ohio, USA.
D000743:Anemia, Hemolytic / Q000139:chemically induced / Q000175:diagnosis / Q000209:etiology* / Q000451:nursing*; D000970:Antineoplastic Agents / Q000009:adverse effects; D001778:Blood Coagulation Disorders / Q000139:chemically induced / Q000175:diagnosis / Q000209:etiology* / Q000451:nursing*; D001853:Bone Marrow / Q000187:drug effects; D006801:Humans; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D012307:Risk Factors; D013921:Thrombocytopenia / Q000209:etiology / Q000451:nursing; D020246:Venous Thrombosis / Q000209:etiology / Q000451:nursing
D000970:Antineoplastic Agents